Skip to main content
锦波生物 logo

锦波生物 — Investor Relations & Filings

Ticker · 920982 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 391 across all filing types
Latest filing 2025-04-20 AGM Information
Country CN China
Listing Beijing Stock Exchange 920982

About 锦波生物

https://www.sxjbswyy.com/

Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of functional proteins through synthetic biology. The company is recognized for its industrialization of recombinant humanized collagen, specifically Type III collagen with a stable triple helix structure. Its core business encompasses the production of medical-grade biomaterials, functional skincare products, and medical devices used in aesthetics, wound healing, and gynecological health. By utilizing advanced protein engineering, the company provides biocompatible solutions designed for tissue repair and anti-aging applications. Its technical focus remains on the structural optimization and large-scale production of high-purity recombinant proteins to meet clinical and consumer health demands.

Recent filings

Filing Released Lang Actions
关于召开2024年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of Shanxi Jinbo Biopharmaceutical Co., Ltd. It includes information about the meeting date, voting methods (including online voting), agenda items to be discussed and approved at the AGM such as the 2024 annual report, financial statements, dividend distribution plan, board and supervisory reports, auditor appointment, and other corporate governance matters. The document also references the availability of the full 2024 annual report and other related documents on the Beijing Stock Exchange information disclosure platform, indicating that this document itself is not the annual report but a notice for the AGM where these reports will be reviewed and approved. The document length is about 5908 characters, which is substantial but the content is clearly a meeting notice and agenda rather than the report itself. Therefore, this document fits the category of AGM Information (AGM-R).
2025-04-20 Chinese
董事会审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee regarding the supervision of the accounting firm (auditor) for the fiscal year 2024. It details the auditor's qualifications, the process of appointment, communication with the auditor, and the audit results including the issuance of an unqualified audit opinion on the company's 2024 financial statements. The document is not the audit report itself but a supervisory report on the auditor's performance and the audit process. It is a standalone audit-related report, not a full annual report or financial statement. Therefore, it fits the category of Audit Report / Information (AR). The document length is under 5,000 characters but contains substantive content about audit supervision, not just an announcement or certification, so it is not RPA or RNS. FY 2024
2025-04-20 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled '年度报告' which translates to 'Annual Report' and covers the fiscal year 2024. It includes detailed sections such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, and financial accounting reports. The document contains comprehensive financial data including income, profit, assets, liabilities, and detailed management analysis. It also includes an auditor's report with an unqualified opinion. The length of the document is about 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of audited financial statements and detailed management discussion confirms this is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-04-20 Chinese
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the storage and actual use of raised funds by Shanxi Jinbo Biopharmaceutical Co., Ltd. It includes specifics on the total amount raised, net proceeds, timing of fund receipt, usage details, changes in fund usage, and compliance with regulatory requirements. It references approvals from the China Securities Regulatory Commission and includes audit verification reports. The document also discusses management of idle funds, investment in financial products, and changes approved by the board and shareholders. The content is focused on the management and use of capital raised through equity issuance, with detailed financial figures and compliance statements. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is substantive and not merely an announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is CAP.
2025-04-20 Chinese
山西锦波生物医药股份有限公司内部控制审计报告
Regulatory Filings
2025-04-20 Chinese
2024年度独立董事述职报告（张金鑫）
Board/Management Information Classification · 95% confidence The document is titled '2024 年度独立董事述职报告' which translates to '2024 Annual Independent Director's Work Report'. It is a detailed report by an independent director about their duties, attendance, supervision, and opinions on company governance and financial matters during the year 2024. The content includes descriptions of board meetings, committee participation, oversight of financial reports, internal controls, and compliance with laws and regulations. It is not an announcement or a brief summary but a substantive report on management and governance activities by a board member. This fits best under the category of Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities. The document is not a full annual report (10-K), audit report (AR), or other financial filings, but a governance-related report by a board member. The length and detail confirm it is a full report, not a mere announcement or certification. Therefore, the classification is MANG with high confidence.
2025-04-20 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.